Quality Compounding Summit: Elevating Excellence

September 8-9, 2017

Embassy Suites OKC Downtown Medical Center

Oklahoma City, OK

Presented by ARL Bio Pharma and the American College of Apothecaries.

On-line conference registration is closed; on-site registration will begin at 7:30 am on September 8.

Please contact Susan Decker, ACA Director of Conferences at 434-989-5938 or susan@acainfo.org for hotel reservations.   


Quality. Verification. Trust.

Quality is a critical ingredient of the medications you compound and the procedures you and your staff follow every day. Quality means that:

  • Pharmacists can verify that the medications they provide are potent, valid, correct, stable, and sterile.  
  • Doctors and patients can trust that you stand behind every prescription you fill.  

As a compounding pharmacist, you know that quality elevates excellence — and protects healthcare organizations and patients worldwide.   

Quality Compounding Summit

The Quality Compounding Summit, presented by ARL Bio Pharma and the American College of Apothecaries, brings together national speakers for a two-day intensive focus on quality issues in compounding.

The Topics You Need

Hear industry leaders from across the country speak on key topics selected to build your pharmacy's success, including best practices, safety, facility design, and regulatory issues. This conference offers 8.0 hours of continuing education.

  • USP <800> California Board of Pharmacy Implementations: How Pharmacists Can Incorporate USP <800> into Facility Design – Tony J. Park, PharmD, JD, California Pharmacy Lawyers 
  • Root Cause Analysis for Compounding Pharmacists – Joe Cabaliero, RPh, Gates Healthcare Associates, LLC
  • Coping with the Changing Compounding Landscape – Loyd V. Allen, Jr., PhD, RPh, International Journal of Pharmaceutical Compounding
  • Microbiology Testing: USP Requirements for Sterile and Non-Sterile Preparations  – Thomas C. Kupiec, PhD, ARL Bio Pharma
  • Extending Beyond Use Dates for Compounded Preparations – Thomas C. Kupiec, PhD, ARL Bio Pharma
  • Multistate Pharmacy Inspection Blueprint Program - State Boards of Pharmacy Regulatory Landscape for Inspections of Compounding Pharmacies  – Elizabeth Scott Russell, RPh, National Association of Boards of Pharmacy
  • Compliance Requirements for Traditional Compounding (503A) and Outsourcing Facilities (503B): Bringing 503B into 503A to Improve Organizational Practices  – Ken Speidel, RPh, PharmD, FACA, FIACP,  LP3 Network.  


Sign up to receive updates on the Quality Compounding Summit.